A kind of universal lentiviral vector and its preparation method
A lentiviral vector and general-purpose technology, applied in the field of lentiviral vectors and their preparation, can solve the problems of high cost, time-consuming, non-universal lentiviral vectors, etc., and achieve stable expression, favorable application, and rapid screening methods
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
specific Embodiment approach 1
[0050] Specific embodiment 1: In this embodiment, the universal lentiviral vector uses the pCDH-CMV-MCS-EF1-Puro plasmid as the backbone, and inserts the following elements into the multiple cloning site MCS of the plasmid backbone: CD8αLeader DNA sequence, CD8α hinge region, CD28 Transmembrane region-intracellular region, CD137 intracellular region and CD3ζ; wherein the CD8αLeader DNA sequence is shown in SEQ ID NO: 1 in the sequence listing, the CD8α hinge region is shown in SEQ ID NO: 2 in the sequence listing, and the CD28 transmembrane region- The intracellular region is shown as SEQ ID NO: 3 in the sequence listing, the intracellular region of CD137 is shown as SEQ ID NO: 4 in the sequence listing, and the CD3ζ is shown as SEQ ID NO: 5 in the sequence listing.
[0051] In this embodiment, a signal sequence, an extracellular hinge region, a membrane binding region, and an intracellular signal transduction region are constructed. The intracellular signal transduction region...
specific Embodiment approach 2
[0052] Specific embodiment two: the preparation method of the universal lentiviral vector in this embodiment, the specific steps are as follows:
[0053] 1. Primer design:
[0054] Design the upstream and downstream primers for CD8α hinge region, CD28 transmembrane region-intracellular region, CD137 intracellular region and CD3ζ, respectively named: CD8αF / CD8αR, CD28F / CD28R, CD137F / CD137R, CD3ζF / CD3ζR;
[0055] 2. Acquisition and activation of peripheral blood mononuclear cells:
[0056] Collect adult peripheral blood, extract peripheral blood mononuclear cells, resuspend peripheral blood mononuclear cells (PBMC) with RPMI1640 medium containing 10% FBS and 1000IU / ml IL-2 and dilute to 1×10 6 / ml-1.5×10 6 / ml, take 2ml of the diluent and add it to the 6-well plate coated with the coating solution in advance, and stimulate for 20-28h.
[0057] 3. mRNA extraction and RT reaction:
[0058] Extracting the RNA of the PBMC activated in step 2, and reverse-transcribing it into cDN...
specific Embodiment approach 3
[0065] Specific embodiment 3: The difference between this embodiment and specific embodiment 2 is that the sequence of primer CD8αF in step 1 is: 5'-CCG GAATTC ACCACGACGCCAGCGCCGC-3', primer CD8αF sequence is: 5'- ACCAGCACCCAAAA ATCACAGGCGAAGTCCAGCCCCCT-3'. Others are the same as in the second embodiment.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com